Current Neuro-Oncology

Volume 25 Number 1
15 January 2023

Home > Publications > Current Neuro-Oncology > Volume 24, Year 2023 > Number 1, 15 January

Vitanza NA, Ronsley R, Choe M, Henson C, Breedt M, Barrios-Anderson A, Wein A, Brown C, Beebe A, Kong A, Kirkey D, Lee BM, Leary SES, Crotty EE, Hoeppner C, Holtzclaw S, Wilson AL, Gustafson JA, Foster JB, Iliff JJ, Goldstein HE, Browd SR, Lee A, Ojemann JG, Pinto N, Gust J, Gardner RA, Jensen MC, Hauptman JS, Park JR.
Locoregional CAR T cells for children with CNS tumors: Clinical procedure and catheter safety.
Neoplasia. 2023 Jan 2, 2023;36:100870
. doi: 10.1016/j.neo.2022.100870. PMID: 36599192. Observational study.

Eichkorn T, Lischalk JW, Hörner-Rieber J, Deng M, Meixner E, Krämer A, Hoegen P, Sandrini E, Regnery S, Held T, Harrabi S, Jungk C, Herfarth K, Debus J, König L.
Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3.
J Neurooncol. 2023 Jan 4
. doi: 10.1007/s11060-022-04217-y. PMID: 36598613. Observational study.

Chan PP, Sabus A, Hemenway MS, Chatfield KC, White CJ, Mirsky DM, Foreman NK, Dahl NA.
Thromboembolic toxicity observed with concurrent trametinib and lenalidomide therapy.
Pediatr Blood Cancer. 2023 Jan 5:e30190
. doi: 10.1002/pbc.30190. PMID: 36602034. Observational study˰

Fung PS, To AH, Lui ST, Leung YC, Liu AP.
Gastric outlet obstruction in a patient with relapsed medulloblastoma on metronomic therapy.
Pediatr Blood Cancer. 2023 Jan 5:e30196
. doi: 10.1002/pbc.30196. PMID: 36602029. Case report˰

Wang X, Li X, Wu Y, Hong J, Zhang M.
The prognostic significance of tumor-associated neutrophils and circulating neutrophils in glioblastoma (WHO CNS5 classification).
BMC Cancer. 2023 Jan 6, 2023;23(1):20
. doi: 10.1186/s12885-022-10492-9. PMID: 36609243. Observational study.

Wang Z, Sun S, Xie K, Miao J.
Glioblastoma in the contralateral cerebral hemisphere with previous surgery for meningioma: A case report.
Medicine (Baltimore). 2023 Jan 6, 2023;102(1):e32616
. doi: 10.1097/MD.0000000000032616. PMID: 36607853. Case report.

Kawauchi D, Ohno M, Honda-Kitahara M, Miyakita Y, Takahashi M, Yanagisawa S, Tamura Y, Kikuchi M, Ichimura K, Narita Y.
Clinical characteristics and prognosis of Glioblastoma patients with infratentorial recurrence.
BMC Neurol. 2023 Jan 7, 2023;23(1):9
. doi: 10.1186/s12883-022-03047-9. PMID: 36609238. Observational study.

Zhao Y, Chen Y, Wang L, Gao Y, Xu J.
The clinicopathological features and prognosis of multifocal high-grade gliomas in adults with H3F3A mutation.
Neurosciences (Riyadh). 2023 Jan 7, 2023;28(1):42-47
. doi: 10.17712/nsj.2023.1.20220080. PMID: 36617452. Observational study.

Platten M, Grassl N.
Vaccines Targeting Gliomas: Antigens Matter.
J Clin Oncol. 2023 Jan 9:JCO2202616
. doi: 10.1200/JCO.22.02616. PMID: 36623232. Comment.
Refers to: Ahluwalia MS, et al., Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma.
J Clin Oncol. 2022 Dec 15:JCO2200996
. doi: 10.1200/JCO.22.00996. PMID: 36521103. Interventional study.

Kataria SP, Mahak, Kumar S, Singh G, Singh S.
Oligodendroglioma metastasizing to cervical lymph node: Rare entity diagnosed on fine-needle aspiration cytology.
Diagn Cytopathol. 2023 Jan 11
. doi: 10.1002/dc.25100. PMID: 36628997. Case report˰

Merchant TE, Wu S, Onar-Thomas A, Gajjar A, Delaney A.
Hypogonadism After Treatment for Medulloblastoma: Results from the SJMB03 Trial of Risk-Adapted Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2023 Jan 11:S0360-3016(23)00008-1. doi: 10.1016/j.ijrobp.2023.01.001. PMID: 36641041. Observational study˰

Chien-Tung Y, Chen CC.
Case report of intracranial large vessel occlusion in glioblastoma multiforme patient after radiation therapy.
Medicine (Baltimore). 2023 Jan 13, 2023;102(2):e32682
. doi: 10.1097/MD.0000000000032682. PMID: 36637940. Case report.

Kleinschmidt-DeMasters BK, Ormond DR.
Leptomeningeal metastases and dural spread in adult high-grade astrocytomas.
J Neuropathol Exp Neurol. 2023 Jan 13:nlac126
. doi: 10.1093/jnen/nlac126. PMID: 36637258. Observational study˰

Sampson JH, Singh Achrol A, Aghi MK, Bankiewiecz K, Bexon M, Brem S, Brenner A, Chandhasin C, Chowdhary S, Coello M, Ellingson BM, Floyd JR, Han S, Kesari S, Mardor Y, Merchant F, Merchant N, Randazzo D, Vogelbaum M, Vrionis F, Wembacher-Schroeder E, Zabek M, Butowski N.
Targeting the IL4 Receptor with MDNA55 in Patients with Recurrent Glioblastoma: Results of a Phase 2b Trial.
Neuro Oncol. 2023 Jan 14:noac285
. doi: 10.1093/neuonc/noac285. PMID: 36640127. Interventional study.